First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.47 USD
Updated: Apr 18, 2024

Intrinsic Value

IDXG doesn't have a meaningful market cap.

Interpace Biosciences, Inc. operates as a bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. [ Read More ]

The intrinsic value of one IDXG stock under the Base Case scenario is 6.46 USD. Compared to the current market price of 1.47 USD, Interpace Biosciences Inc is Undervalued by 77%.

Key Points:
IDXG Intrinsic Value
Base Case
6.46 USD
Undervaluation 77%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Interpace Biosciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IDXG stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Interpace Biosciences Inc

Provide an overview of the primary business activities
of Interpace Biosciences Inc.

What unique competitive advantages
does Interpace Biosciences Inc hold over its rivals?

What risks and challenges
does Interpace Biosciences Inc face in the near future?

Has there been any significant insider trading activity
in Interpace Biosciences Inc recently?

Summarize the latest earnings call
of Interpace Biosciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Interpace Biosciences Inc.

Provide P/S
for Interpace Biosciences Inc.

Provide P/E
for Interpace Biosciences Inc.

Provide P/OCF
for Interpace Biosciences Inc.

Provide P/FCFE
for Interpace Biosciences Inc.

Provide P/B
for Interpace Biosciences Inc.

Provide EV/S
for Interpace Biosciences Inc.

Provide EV/GP
for Interpace Biosciences Inc.

Provide EV/EBITDA
for Interpace Biosciences Inc.

Provide EV/EBIT
for Interpace Biosciences Inc.

Provide EV/OCF
for Interpace Biosciences Inc.

Provide EV/FCFF
for Interpace Biosciences Inc.

Provide EV/IC
for Interpace Biosciences Inc.

Show me price targets
for Interpace Biosciences Inc made by professional analysts.

What are the Revenue projections
for Interpace Biosciences Inc?

How accurate were the past Revenue estimates
for Interpace Biosciences Inc?

What are the Net Income projections
for Interpace Biosciences Inc?

How accurate were the past Net Income estimates
for Interpace Biosciences Inc?

What are the EPS projections
for Interpace Biosciences Inc?

How accurate were the past EPS estimates
for Interpace Biosciences Inc?

What are the EBIT projections
for Interpace Biosciences Inc?

How accurate were the past EBIT estimates
for Interpace Biosciences Inc?

Compare the revenue forecasts
for Interpace Biosciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Interpace Biosciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Interpace Biosciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Interpace Biosciences Inc compared to its peers.

Compare the P/E ratios
of Interpace Biosciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Interpace Biosciences Inc with its peers.

Analyze the financial leverage
of Interpace Biosciences Inc compared to its main competitors.

Show all profitability ratios
for Interpace Biosciences Inc.

Provide ROE
for Interpace Biosciences Inc.

Provide ROA
for Interpace Biosciences Inc.

Provide ROIC
for Interpace Biosciences Inc.

Provide ROCE
for Interpace Biosciences Inc.

Provide Gross Margin
for Interpace Biosciences Inc.

Provide Operating Margin
for Interpace Biosciences Inc.

Provide Net Margin
for Interpace Biosciences Inc.

Provide FCF Margin
for Interpace Biosciences Inc.

Show all solvency ratios
for Interpace Biosciences Inc.

Provide D/E Ratio
for Interpace Biosciences Inc.

Provide D/A Ratio
for Interpace Biosciences Inc.

Provide Interest Coverage Ratio
for Interpace Biosciences Inc.

Provide Altman Z-Score Ratio
for Interpace Biosciences Inc.

Provide Quick Ratio
for Interpace Biosciences Inc.

Provide Current Ratio
for Interpace Biosciences Inc.

Provide Cash Ratio
for Interpace Biosciences Inc.

What is the historical Revenue growth
over the last 5 years for Interpace Biosciences Inc?

What is the historical Net Income growth
over the last 5 years for Interpace Biosciences Inc?

What is the current Free Cash Flow
of Interpace Biosciences Inc?

Financials

Balance Sheet Decomposition
Interpace Biosciences Inc

Current Assets 11.4m
Cash & Short-Term Investments 5m
Receivables 4.8m
Other Current Assets 1.6m
Non-Current Assets 2.9m
PP&E 2.7m
Other Non-Current Assets 200k
Current Liabilities 12.3m
Accounts Payable 1.4m
Accrued Liabilities 8.9m
Other Current Liabilities 2m
Non-Current Liabilities 18.1m
Long-Term Debt 11.6m
Other Non-Current Liabilities 6.5m
Efficiency

Earnings Waterfall
Interpace Biosciences Inc

Revenue
38.2m USD
Cost of Revenue
-15.4m USD
Gross Profit
22.8m USD
Operating Expenses
-21.2m USD
Operating Income
1.6m USD
Other Expenses
-3.2m USD
Net Income
-1.6m USD

Free Cash Flow Analysis
Interpace Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

IDXG Profitability Score
Profitability Due Diligence

Interpace Biosciences Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

45/100
Profitability
Score

Interpace Biosciences Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

IDXG Solvency Score
Solvency Due Diligence

Interpace Biosciences Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
42/100
Solvency
Score

Interpace Biosciences Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDXG Price Targets Summary
Interpace Biosciences Inc

There are no price targets for IDXG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

IDXG Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

IDXG Price
Interpace Biosciences Inc

1M 1M
-2%
6M 6M
+63%
1Y 1Y
+34%
3Y 3Y
-82%
5Y 5Y
-79%
10Y 10Y
-100%
Annual Price Range
1.47
52w Low
0.83
52w High
2.91
Price Metrics
Average Annual Return -5.65%
Standard Deviation of Annual Returns 91.05%
Max Drawdown -94%
Shares Statistics
Market Capitalization 6.3m USD
Shares Outstanding 4 320 000
Percentage of Shares Shorted 1.18%

IDXG Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Interpace Biosciences Inc Logo
Interpace Biosciences Inc

Country

United States of America

Industry

Health Care

Market Cap

6.3m USD

Dividend Yield

0%

Description

Interpace Biosciences, Inc. operates as a bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. The company is headquartered in Parsippany, New Jersey and currently employs 147 full-time employees. The Company’s clinical services provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating the risk of cancer in personalized medicine for improved patient diagnosis and management. Through its pharma services, it develops, commercializes and provides molecular and biomarker-based tests and services. Its pharma services provide pharmacogenomics testing, genotyping, biorepository and other specialized services to the pharmaceutical and biotech industries and advance personalized medicine. The firm has five commercialized molecular diagnostic tests in the marketplace, which include PancraGEN, PanDNA, ThyGeNEXT, ThyraMIR and RespriDx. Its pipeline product includes BarreGEN.

Contact

NEW JERSEY
Parsippany
Morris Corporate Center 1,, Building C, 300 Interpace Parkway
+14122246100.0
https://www.interpace.com/

IPO

1998-05-19

Employees

147

Officers

President, CEO & Chairman
Dr. Thomas W. Burnell Ph.D.
Chief Financial Officer
Mr. Christopher McCarthy
Chief Scientific Officer
Dr. Sydney D. Finkelstein
Chief Revenue Officer
Mr. Jody Campbell
Chief Medical Officer
Dr. Nicole Massoll M.D.
VP & Corporate Controller
Mr. Patrick Kane

See Also

Discover More
What is the Intrinsic Value of one IDXG stock?

The intrinsic value of one IDXG stock under the Base Case scenario is 6.46 USD.

Is IDXG stock undervalued or overvalued?

Compared to the current market price of 1.47 USD, Interpace Biosciences Inc is Undervalued by 77%.